Correlation between Flicker-Induced Retinal Vessel Vasodilatation and Plasma Biomarkers of Endothelial Dysfunction in Hypertensive Patients

References

• Polak K, Schmetterer L, Riva CE. Influence of flicker frequency on flicker-induced changes of retinal vessel diameter. Invest Ophthalmol Vis Sci. 2002;43:2721–26.
   PubMed Web of Science ®Google Scholar
• Garhofer G, Huemer KH, Zawinka C, Schmetterer L, Dorner GT. Influence of diffuse luminance flicker on choroidal and optic nerve head blood flow. Curr Eye Res. 2002;24:109–13. doi:10.1076/ceyr.24.2.109.8164.
   PubMed Web of Science ®Google Scholar
• Kotliar KE, Vilser W, Nagel E, Lanzl IM. Retinal vessel reaction in response to chromatic flickering light. Graefes Arch Clin Exp Ophthalmol. 2004;242:377–92. doi:10.1007/s00417-003-0847-x.
   PubMed Web of Science ®Google Scholar
• Nagel E, Vilser W. Autoregulative behavior of retinal arteries and veins during changes of perfusion pressure: a clinical study. Graefes Arch Clin Exp Ophthalmol. 2004;242:13–17. doi:10.1007/s00417-003-0663-3.
   PubMed Web of Science ®Google Scholar
• Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging. 2008;1:156–61. doi:10.1161/CIRCIMAGING.108.784876.
   PubMed Web of Science ®Google Scholar
• DellaCroce JT, Vitale AT. Hypertension and the eye. Curr Opin Ophthalmol. 2008;19:493–98. doi:10.1097/ICU.0b013e3283129779.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Paoletti V, Davì G. Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis. 2006;16:222–33. doi:10.1016/j.numecd.2005.11.012.
   PubMed Web of Science ®Google Scholar
• Coban E, Nizam I, Topal C, Akar Y. The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens. 2010;32:528–351. doi:10.3109/10641963.2010.496519.
   PubMed Web of Science ®Google Scholar
• Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, Dellsperger K, Zhang C. Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond). 2009;116:219–30. doi:10.1042/CS20080196.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007;49:304–10. doi:10.1161/01.HYP.0000252664.24294.ff.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G. Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascularendothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag. 2011;7:475–82. doi:10.2147/VHRM.S23097.
   PubMedGoogle Scholar
• Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension. 2007;50:723–28. doi:10.1161/HYPERTENSIONAHA.107.093120.
   PubMed Web of Science ®Google Scholar
• X.World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Jama. 2013;310:2191–94. doi:10.1001/jama.2013.281053.
   PubMed Web of Science ®Google Scholar
• Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis risk in communities study. Ophthalmology. 1999;106:2269–80. doi:10.1016/S0161-6420(99)90525-0.
   PubMed Web of Science ®Google Scholar
• Brückmann A, Seeliger C, Lehmann T, Schleußner E, Schlembach D. Altered retinal flicker response indicates microvascular dysfunction in women with preeclampsia. Hypertension. 2015;66:900–05. doi:10.1161/HYPERTENSIONAHA.115.05734.
   PubMed Web of Science ®Google Scholar
• Schuster AK, Fischer JE, Vossmerbaeumer C, Vossmerbaeumer U. Optical coherence tomography-based retinal vessel analysis for the evaluation of hypertensive vasculopathy. Acta Ophthalmol. 2015;93:e148–153. doi:10.1111/aos.12509.
   PubMed Web of Science ®Google Scholar
• Sainani GS, Maru VG. Role of endothelial cell dysfunction in essential hypertensio. J Assoc Physicians India. 2004;52:966–69.
   PubMedGoogle Scholar
• Echevarria FD, Rickman AE, Sappington RM. Interleukin-6: A constitutive modulator of Glycoprotein 130, neuroinflammatory and cell survival signaling in retina. J Clin Cell Immunol. 2016;7:pii:439. doi:10.4172/2155-9899.1000439.
   PubMedGoogle Scholar
• Sahakyan K, Klein BE, Myers CE, Tsai MY, Klein R. Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus. Am Heart J. 2010;159:1074–80. doi:10.1016/j.ahj.2010.03.023.
   PubMed Web of Science ®Google Scholar
• Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149–54. doi:10.1038/sj.jhh.1001785.
   PubMed Web of Science ®Google Scholar
• Van Den Born BJ, Hulsman CA, Hoekstra JB, Schlingemann RO, Van Montfrans GA. Value of routine funduscopy in patients with hypertension: systematic review. Bmj. 2005;331:73. doi:10.1136/bmj.331.7508.73.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Knudtson MD, Wong TY. Tsai MY are inflammatory factors related to retinal vessel caliber? The beaver dam eye study. Arch Ophthalmol. 2006;124:87–94. doi:10.1001/archopht.124.1.87.
   PubMedGoogle Scholar
• Lopes De Faria JB, Silva KC, Lopes De Faria JM. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. 2011;34:413–22. doi:10.1038/hr.2010.263.
   PubMed Web of Science ®Google Scholar
• Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, Horio T, Kawano Y. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens. 2004;18:17–23. doi:10.1038/sj.jhh.1001628.
   PubMed Web of Science ®Google Scholar
• Ebinc H, Ebinc FA, Ozkurt ZN. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure. Saudi Med J. 2007;28:472–83.
   PubMed Web of Science ®Google Scholar
• Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li R-K, Mickle DAG, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–19. doi:10.1161/01.CIR.0000029802.88087.5E.
   PubMed Web of Science ®Google Scholar
• Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res. 2006;99:69–77. doi:10.1161/01.RES.0000229685.37402.80.
   PubMed Web of Science ®Google Scholar
• Zoccali C. Endothelial dysfunction in CKD: a new player in town? Nephrol Dial Transplant. 2008;23:783–85. doi:10.1093/ndt/gfm924.
   PubMed Web of Science ®Google Scholar
• Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, Hijii C, Yanagawa M, Ogasawara M, Nishioka K. Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol. 2001;28:188–92. doi:10.1046/j.1440-1681.2001.03429.x.
   PubMed Web of Science ®Google Scholar
• Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A. Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res. 2002;25:475–80. doi:10.1291/hypres.25.475.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Pérez A, Richart C, Engel P, et al. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2002;282:E952–959. doi:10.1152/ajpendo.00444.2001.
   PubMed Web of Science ®Google Scholar
• Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205–09. doi:10.1161/01.RES.73.1.205.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289:2560–72. doi:10.1001/jama.289.19.2560.
   PubMed Web of Science ®Google Scholar
• Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Lüscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A; ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens. 2003;21:1779–86. doi:10.1097/00004872-200310000-00001.
   PubMedGoogle Scholar
• Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR, Mitchell P. Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the blue mountains eye study. Hypertension. 2004;44:442–47. doi:10.1161/01.HYP.0000140772.40322.ec.
   PubMed Web of Science ®Google Scholar
• Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003;285:H631–H636. doi:10.1152/ajpheart.00111.2003.
   PubMed Web of Science ®Google Scholar
• Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci. 2004;45:1486–92. doi:10.1167/iovs.03-0667.
   PubMed Web of Science ®Google Scholar
• Garhöfer G, Zawinka C, Huemer KH, Schmetterer L, Dorner GT. Flicker light-induced vasodilatation in the human retina: effect of lactate and changes in mean arterial pressure. Invest Ophthalmol Vis Sci. 2003;44:5309–14. doi:10.1167/iovs.03-0587.
   PubMed Web of Science ®Google Scholar
• Garhöfer G, Resch H, Weigert G, Lung S, Simader C, Schmetterer L. Short-term increase of intraocular pressure does not alter the response of retinal and optic nerve head blood flow to flicker stimulation. Invest Ophthalmol Vis Sci. 2005;46:1721–25. doi:10.1167/iovs.04-1347.
   PubMed Web of Science ®Google Scholar
• Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–98.
   PubMedGoogle Scholar
• Frick M, Weidinger F. Endothelial function: A surrogate endpoint in cardiovascular studies? Curr Pharm Des. 2007;13:1741–50. doi:10.2174/138161207780831211.
   PubMed Web of Science ®Google Scholar
• Kiowski W, Linder L, Nuesch R, Martina B. Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;27:371–76. doi:10.1161/01.HYP.27.3.371.
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000;35:60–66. doi:10.1016/S0735-1097(99)00537-9.
   PubMed Web of Science ®Google Scholar
• Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HAJ. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118:968–76. doi:10.1161/CIRCULATIONAHA.107.763730.
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens. 2001;19:547–51. doi:10.1097/00004872-200103001-00005.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Kotani K, Ishibashi S, Taniguchi N. The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients. Int J Vasc Med. 2012;2012:453264.
   PubMedGoogle Scholar
• Bleakley C, Hamilton PK, Pumb R, Harbinson M, McVeigh GE. Endothelial function in hypertension: victim or culprit? J Clin Hypertens (Greenwich). 2015;17:651–54. doi:10.1111/jch.12546.
   PubMed Web of Science ®Google Scholar